Medications for Major Depressive Disorder
235 results
Abilify (aripiprazole)
(ARIPIPRAZOLE)Otsuka America Pharmaceutical, Inc.
Usage: ABILIFY (aripiprazole) Tablets are indicated for the treatment of schizophrenia, acute manic and mixed episodes in Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder.
Abilify (aripiprazole)
(ARIPIPRAZOLE)Carilion Materials Management
Usage: ABILIFY is indicated for treating schizophrenia, acute manic or mixed episodes in Bipolar I Disorder, adjunctive treatment of Major Depressive Disorder, irritability in autistic disorder, and Tourette’s disorder. The injectable form is used for agitation related to schizophrenia or bipolar mania.
Abilify (aripiprazole)
(ARIPIPRAZOLE)Rebel Distributors Corp.
Usage: ABILIFY is indicated for the treatment of schizophrenia, bipolar I disorder (both monotherapy and adjunctive therapy), major depressive disorder as an adjunct to antidepressants, irritability associated with autistic disorder, and acute agitation related to schizophrenia or bipolar disorder.
Abilify mycite (aripiprazole)
(ARIPIPRAZOLE)Otsuka America Pharmaceutical, Inc.
Usage: ABILIFY MYCITE is indicated for treating adults with schizophrenia, bipolar I disorder (both acute and maintenance treatment), and as adjunctive therapy for adults with Major Depressive Disorder. It consists of aripiprazole tablets embedded with a sensor to track drug ingestion. Compliance improvement and real-time tracking are not established.
Aplenzin (bupropion hydrobromide )
(BUPROPION HYDROBROMIDE)STAT RX USA LLC
Usage: Aplenzin™ (bupropion hydrobromide extended-release) is indicated for treating major depressive disorder, established through controlled trials. It helps maintain antidepressant response following initial treatment. Long-term use should be periodically reevaluated by the physician for individual patient benefit.
Aplenzin (bupropion hydrobromide)
(bupropion hydrobromide)Bausch Health US, LLC
Usage: APLENZIN (bupropion hydrobromide) is indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Its efficacy was established through multiple controlled trials involving adult patients with these conditions.
Aripiprazole (aripiprazole)
(Aripiprazole)Ascend Laboratories, LLC
Usage: Aripiprazole Oral Tablets are indicated for treating schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, as an adjunctive treatment for Major Depressive Disorder, irritability associated with autistic disorder, and Tourette’s disorder.
Aripiprazole (aripiprazole)
(ARIPIPRAZOLE)Accord Healthcare, Inc.
Usage: Aripiprazole tablets are indicated for the treatment of schizophrenia, acute manic and mixed episodes in bipolar I disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder.
Aripiprazole (aripiprazole)
(Aripiprazole)Amneal Pharmaceuticals LLC
Usage: Aripiprazole oral solution is indicated for treating schizophrenia, acute manic and mixed episodes in Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.
Bupropion (bupropion hydrochloride)
(bupropion hydrochloride)Northwind Pharmaceuticals, LLC
Usage: Bupropion hydrochloride extended-release (SR) tablets are approved for treating major depressive disorder (MDD) in adults. Efficacy was established in controlled trials, demonstrating effectiveness in both acute treatment and maintenance of antidepressant response for up to 44 weeks post-treatment.
- ...